Q1 26 EPS
$7.79
BEAT +2.42%
Est. $7.61
Q1 26 Revenue
$68.49B
BEAT +3.46%
Est. $66.20B
vs S&P Since Q1 26
-8.4%
TRAILING MARKET
CI -4.5% vs S&P +3.9%
Market Reaction
Did CI Beat Earnings? Q1 2026 Results
The Cigna Group delivered a strong start to 2026, posting first-quarter adjusted earnings of $7.79 per share, up from $6.74 a year ago, marking the company's fourth consecutive quarter of beating consensus EPS estimates. Total revenues climbed 5% yea… Read more The Cigna Group delivered a strong start to 2026, posting first-quarter adjusted earnings of $7.79 per share, up from $6.74 a year ago, marking the company's fourth consecutive quarter of beating consensus EPS estimates. Total revenues climbed 5% year-over-year to $68.49 billion, with Evernorth Health Services serving as the primary engine, its Specialty and Care Services unit driving a 20% surge in pre-tax income on robust specialty volume growth and rising biosimilar adoption. Adjusted income from operations rose 12% to $2.06 billion, while GAAP net income came in at $1.65 billion, or $6.26 per share, compared to $1.32 billion, or $4.85 per share, in the prior-year period. Cigna Healthcare's medical care ratio improved meaningfully to 79.8% from 82.2%, aided by the exit from Medicare businesses completed in early 2025. Encouraged by the momentum, management raised its full-year 2026 adjusted income from operations outlook by $0.10 to at least $30.35 per share, with Cigna Healthcare's segment target lifted by $25 million to at least $4.53 billion.
Key Takeaways
- • Evernorth Health Services revenue growth driven by drug mix changes in Pharmacy Benefit Services and strong specialty volume growth in Specialty and Care Services
- • Cigna Healthcare adjusted pre-tax income increased 18% driven by improved margins in U.S. Employer and Individual and Family Plan businesses
- • Increased generic and biosimilar adoption lowering costs for clients and patients
- • Premium rate increases to cover expected increases in medical costs
- • Improved SG&A expense ratio reflecting business mix shift and operating efficiency
- • Medical care ratio improved to 79.8% from 82.2% primarily reflecting the HCSC transaction impact
CI Forward Guidance & Outlook
The Cigna Group raised its full-year 2026 outlook for adjusted income from operations to at least $30.35 per share, an increase of $0.10 from the prior projection. Evernorth adjusted income from operations, pre-tax, is projected at at least $6,900 million (unchanged). Cigna Healthcare adjusted income from operations, pre-tax, is projected at at least $4,525 million, raised by $25 million. Cigna Healthcare medical care ratio is expected at 83.7% to 84.7%. The outlook includes the impact of expected future share repurchases and anticipated 2026 dividends, and excludes potential effects of business combinations after the filing date.
CI YoY Financials
Q1 2026 vs Q1 2025, source: SEC Filings
CI Revenue by Segment
With YoY comparisons, source: SEC Filings
“We continue to improve how people experience health care, leveraging innovation and technology to make it more personalized, more transparent and easier to navigate.”
— David M. Cordani, Q1 2026 Earnings Press Release
CI Earnings Trends
CI vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
CI EPS Trend
Earnings per share: estimate vs actual
CI Revenue Trend
Quarterly revenue: estimate vs actual
CI Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 BEAT | $7.61 | $7.79 | +2.42% | $68.49B | +3.46% |
| Q4 25 BEAT FY | $7.88 | $8.08 | +2.50% | $72.47B | +4.91% |
| FY Full Year | — | $29.84 | — | $274.90B | — |
| Q3 25 BEAT | $7.64 | $7.83 | +2.47% | $69.75B | +4.50% |
| Q2 25 BEAT | $7.15 | $7.20 | +0.65% | $67.18B | +7.30% |
| Q1 25 BEAT | $6.35 | $6.74 | +6.17% | $65.50B | +8.48% |